Genovis certified to ISO 9001:2015

Quality certification means that the management system meets the requirements imposed by International Standard ISO 9001:2015. The certification covers product development, production and sales. 

By designing a quality management system with a strong customer focus in which all processes and procedures are meticulously formulated and quality-tested in compliance with the international standard, Genovis ensures that it continues to deliver products and provide services that meet market demands.

“Certifying our quality management system to ISO 9001:2015 is an important step to further establish Genovis as a reliable supplier to the global biopharma industry. For our continued growth journey, the certification will be of significance as our customers increasingly use our products further down the value chain for quality analysis of biopharmaceuticals. The certification is the result of a prioritized, continually ongoing systematic effort that enables us to offer high-value products to our customers,” says Fredrik Olsson, CEO of Genovis.

For more information, please contact: Fredrik Olsson, CEO, Genovis AB Tel: 0046 (0)46 -101233



Genovis’ business concept is to apply its knowledge and imagination to design and provide innovative tools for the development of the drugs of the future. Today Genovis sells several enzyme products known as SmartEnzymes all over the world in innovative product formats that facilitate development and quality control of biological drugs.

The Group consists of Genovis AB and the wholly owned subsidiary Genovis Inc. (USA). Genovis shares are listed on Nasdaq First North Stockholm and Erik Penser Bank is the Company’s Certified Adviser. T: +46 (0)8-463 83 00.

This press release is a translation of the Swedish original. In the event of any discrepancy between this translation and the Swedish original, the Swedish version shall prevail.

Back to news